Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial
| Autor: | Gluz, O. *, Nitz, U.A., Harbeck, N., Ting, E., Kates, R., Herr, A., Lindemann, W., Jackisch, C., Berdel, W.E., Kirchner, H., Metzner, B., Werner, F., Schütt, G., Frick, M., Poremba, C., Diallo-Danebrock, R., Mohrmann, S. |
|---|---|
| Zdroj: | In Annals of Oncology May 2008 19(5):861-870 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|